Clinical Trial Update: Effect of Pharmacologic Interaction Between ERAs and PDE-5 Inhibitors on Medication Serum Levels and Clinical Disease Status in Patients With PAH

View source ↗

Summary

A completed clinical trial evaluated how pharmacologic interactions between ERA therapies and PDE-5 inhibitors affect drug serum levels and clinical status in p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Snippet

Sponsor: Heidelberg University | Conditions: Pulmonary Arterial Hypertension | Status: COMPLETED | Results posted: 2020-02-05